Consistent, Managed Treatment Works Best for Children With AD/HD

LANDOVER, Md., Nov. 16 According to the recently released follow-up study to the Multimodal Treatment Study on Attention-Deficit/Hyperactivity Disorder (MTA) in the August issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), children and young people with AD/HD who received carefully managed medication alone or in combination with behavioral management and educational adaptations fared better than children who did not. However, study participants who no longer received intensive interventions and returned to standard community-based care had lost the initial advantages after three years.

These findings show highly intensive treatment works best when begun early and consistently maintained. If high quality treatment is not continued, the initial benefits may be lost several years later. Lead researcher Peter Jensen, M.D., has emphasized the need for parents and healthcare providers to work closely together for the benefit of the child affected by AD/HD. Unfortunately, recent reports in the media have misrepresented the MTA's findings and drawn unsubstantiated conclusions.

CHADD, Children and Adults with Attention-Deficit/Hyperactivity Disorder, encourages each family to work with their healthcare providers for the most effective treatment for their families and children affected by AD/HD.

To read an interview with Jensen concerning the findings, go to http://www.chadd.org/AM/Template.cfm?Section=Press_Releases1&Template=/CM/ContentDisplay.cfm&ContentID=5158.

SOURCE CHADD

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...